ArticleBlood advances2022

Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft models.

Chi-Heng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.